-
A companion for the ATTR-CM journey
The information, insights and support you need every step of the way
Find what you are looking for no matter where you are on the ATTR-CM journey. Get started today.
READ MORE -
Vutrisiran's maker expects a decision by March
FDA evaluates supplemental application for vutrisiran for ATTR-CM
The U.S. Food and Drug Administration is currently evaluating a supplemental new drug application for vutrisiran.
READ MORE -
More study is needed
Tafamidis shows long-term benefits in slowing ATTR-CM
Treatment with tafamidis over nine years demonstrated sustained benefits in slowing the progression of ATTR-CM.
READ MORE -
The right treatment can help
How TTR stabilizers work in managing ATTR-CM
ATTR-CM reatments can include transthyretin (TTR) stabilizers.
READ MORE
The Latest In ATTR-CM News
More news-
-
Most patients with ATTR-CM are in advanced stages despite recent diagnosis: study
-
Ventilation abnormalities are key in ATTR-CM exercise limitation, study says
-
FDA evaluates supplemental application for vutrisiran to treat patients with ATTR-CM
-
Tafamidis shows long-term benefits in slowing ATTR-CM progression
Your ATTR-CM Journey
Click below for a selection of articles customized just for you
ATTR-CM Basics
New to ATTR-CM? Start here to find out about symptoms, diagnosis, treatment and more.
Overview
